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ABSTRACT
OBJECTIVE: The objective of this systematic review is to determine whether or not honey could
be used as an effective topical treatment for diabetic foot ulcers in diabetic patients.
STUDY DESIGN: Review of three primary journal articles published in English between the
years of 2008 and 2010.
DATA SOURCES: Two Randomized Controlled Trials comparing honey as a treatment for
diabetic foot ulcers to either previous failed treatments or Povidone Iodine Solution, and a pilot
prospective study, exploring the effectiveness of PEDYPHAR a royal jelly ointment. All articles
were found using Pubmed, OVID and Cochrane Database.
OUTCOMES MEASURED: Healing time and percent of patients to reach wound closure or a
state of healing ready for surgical closure was assessed in all of the studies. Healing was assessed
by surgeons and was determined based on size of the ulcer and change in grade and stage using
either the University of Texas Diabetic Wound Classification or the Wagner Classification,
inflammation, presence of bacterial cultures and, presence of exudate.
RESULTS: The Shukrimi et al. study showed that honey used as a dressing for diabetic foot
ulcers was as effective as the control group using Povidone Iodine in days for healing. Moghazy
et al. demonstrated that honey used on different stages of diabetic foot ulcers was effective at
providing healing in a relatively short duration. The pilot prospective study by Abdelatif et al.
also portrayed efficient healing with the use of PEDYPHAR and healing time was completed in
a timely manner. The only side affect noted in the three studies was in the pilot prospective
study. Four patients encountered mild burning with application of the PEDYPHAR ointment, but
still continued with its use.
CONCLUSIONS: All studies showed that honey was effective in allowing for healing
improvements in treating diabetic foot ulcers. Further studies are needed to assess the stages in
which honey is most efficient in healing and where surgery may be necessary before use of
honey. In addition, comparing honey that is raw versus honey that has been heat-treated as is the
kind for consumer consumption.
KEY WORDS: Honey and Diabetic Foot Ulcers
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INTRODUCTION
Diabetes Mellitus is a chronic disease that is distinguished by high levels of glucose in
the blood. Two types of the disease exist. Type 1 presents early in life and is an autoimmune
condition where insulin producing beta islet cells of the pancreas are destroyed. Type 2 occurs
due to a combination of insulin resistance of target cells and insufficient production of insulin.1,2
Insulin is the hormone accountable for the metabolism of sugar, carbohydrates and other foods,
without it sugar remains in the blood and is not utilized by muscles and other tissues of the body.
The increase in blood glucose levels for extended periods of time can result in damage to tissues,
organs and nerves. Many complications of diabetes occur in the kidneys, eyes, heart, blood
vessels and feet.1
Diabetes is the leading cause of non-traumatic lower extremity amputations in the United
States.3 This complication is commonly a result of untreated foot ulcers or infection of the lower
leg and foot.3 Diabetic foot ulcers are a chronic complication of diabetes. They exist due to a
combination of other problems that are caused by diabetes including peripheral neuropathy,
peripheral arterial disease (PAD), and trauma to the foot.1,2,3
Peripheral sensory neuropathy is one of the major reasons foot ulcers form. The
neuropathy is caused by the deterioration of the nerves of the extremities which decreases
sensation of pain and temperature in the foot.1,2 The decrease in sensation allows for major or
recurring minor traumas to go unnoticed. Ulcers will develop in those areas that have increased
pressure upon them including most commonly the heel and the underside or tips of the toes.1 In
addition to sensory loss, some motor deficits and muscle weakness result due to the nerve
damage. This combination of motor and sensory loss causes a change in the mechanics of the
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foot causing for pressures to be placed on areas not normally exposed to this type of stress. This
increases the risk for ulcer formation.2,3
The other major factor in foot ulcer development is peripheral arterial disease. This is
caused by plaque buildup in the arteries which eventually decreases blood flow to the small
vessels in the periphery of the feet.1,2,3 With a considerable decrease in blood flow, wounds are
unable to heal due to the lack of oxygen, nutrients, and white blood cells all of which are carried
in the blood.1 With the combination of peripheral neuropathy, change in foot mechanics causing
an increase in trauma, and lack of blood flow to the lower extremity, diabetes patients are very
vulnerable to ulcers of the foot with an inability to heal these wounds in a usual time period.1,2,3
Diabetes is a very common disease that affects approximately 25.8 million people.4 Of
those patients 6.9% will have a foot ulcer in their lifetime.4,5 There are approximately 80,000
amputations done each year on diabetics and 80% of total amputations each year are due to
ulcerations.4,5,6 In 2007, the CDC reported $174 billion was used in treatments for diabetic
patients.7 The average cost of healing one single ulcer is around $8,000, if the ulcer is infected
that cost increases to approximately $17,000.6 Hospital inpatient visits for diabetics reach
numbers of 691,000 and foot complications are the most common cause of these visits.6,7,8
There is no cure for diabetes so the goal is to treat the disease early by first changing
patient’s lifestyles by encouraging incorporation of a healthy diet, decreased sugar intake, and
increased physical activity. After lifestyle changes the next step is to use oral medications to
decrease blood sugars like Metformin, Sulfonyureas and Increatins in addition to using injectable
insulin.2,3 Also, comorbidities such as hyperlipidemia and hypertension are treated to avoid
chronic complications.2,3 Ulcers are a common complication of diabetes, and their regular
treatment includes debridement, irrigation, and application of some type of dressing including
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hydrogels, foams, iodine, absorbant polymers or skin replacements. These dressings help to keep
the wound moist for autolytic breakdown and healing as well as provide an antibacterial
component. It is also important to protect against systemic infection so antibiotics are commonly
given.1,2,3 If treatment is not effective the ultimate result is amputation.2,3 The treatment of
diabetic foot ulcers has been expensive and the time of wound healing has historically been
extensive.2,3,5 In this paper, honey is proposed as a topical dressing option that is both a cheaper
and more accessible alternative with an equal efficacy as other dressing agents in its ability
decrease bacterial load and promote ulcer healing.
Keywords: Diabetes Mellitus, foot ulcers, honey dressing, Diabetic foot ulcers
OBJECTIVE
The objective of this systematic review is to determine whether or not honey could be
used as an effective wound dressing option in the treatment of diabetic foot ulcers.
METHODS
The criteria used for selection of studies included for the population any age and either
gender patients that currently had a diabetic foot ulcer at any stage. Other inclusion criteria was
used and varied between the individual studies. Abdelatif et al. 2008 included those patients that
had limb threatening foot ulcers that were full thickness, greater than 2cm in diameter, with signs
of cellulitis.8 Shukrimi et al. 2008 used inclusion criteria including only patients with non-insulin
dependent diabetes and Wegner’s grade-II Ulcers between the ages of 35-65, a transcutaneous
oxygen tension of >30mmHg, and serum albumin >35g/dL.9
Exclusion criteria also varied between studies. Abdelatif et al. 2008 excluded patients that
were younger than 18 or older than 70 years old. No patient could have been diagnosed with
septicemia, septic shock, or multiple organ dysfunction syndrome.8 Moghazy et al. excluded
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anyone pending amputation or immunocompromised patients5, and Shukrimi et al. 2008
excluded patients with multiple medical comorbidities, using steroid therapy, or a neutraphil
count less than 2000/mm3.9
The intervention used in each of the studies was honey as a dressing for the wound care
of diabetic foot ulcers. Of the three studies used in this review two are randomized controlled
trials (RCT) and the third is a pilot prospective study. The study by Moghazy et al. 2010, one of
the RCTs compared honey dressing to failed treatments that were previously done before this
study began and the wound had no improvement for 3 months.5 Shukrimi et al. 2008, compared
the honey dressing to a more common dressing solution, Povidine iodine.9 The final study by
Abdelatif et al. 2008, the pilot prospective study investigated the effects of PEDYPHAR a new
honey ointment in healing limb threatening diabetic ulcers.8 The outcomes measured in all of the
studies included healing time and percent of patients that were considered healed by the end of
the study. Healing was determined by size, grade, and stage of the ulcer using the University of
Texas Diabetic Wound Classification and Wagner classification, as well as presence and type of
exudates, and microbacterial load.
Key words in literature searches included honey and diabetic foot ulcers, honey and
diabetes. All articles selected were published in English in peer-reviewed journals between the
years 2008-2010. Literature searches were conducted using OVID, Pubmed and Cochrane
database. The articles were selected based on clinical relevance to the topic question and if they
included outcomes that were important to patients (POEMS). Inclusion criteria for articles
included randomized, single blind, prospective studies with patient oriented outcomes published
after 1996. Exclusion criteria included articles published before 1996, and articles with patients
that had other diseases in addition to diabetes that may affect results. Statistics used included p-
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value, relative risk ratio (RRR), absolute risk ratio (ARR), and number needed to treat (NNT).
The demographics of the studies used in this review are included in Table 1.
Table 1. Demographics of Included Studies
Study

Type

# of
pts
60

Age

Inclusion criteria

Abdelatif
(2008)8

Prospective
pilot study

Moghazy
(2010)5

Shukrimi
(2008)9

Exclusion
Criteria
-age <18 or
>70 yo
-septicemia,
septic shock or
multiple organ
dysfunction
syndrome

W/D

Interventions

18-70

-limb-threatening
diabetic foot ulcer
(full thickness,
>2cm in diameter,
with signs of
cellulitis)

0

-all patients with
diabetic foot
ulcers

- pending
amputation,
and immunecompromise
patients

0

-non insulin
dependent DM
patients with Type
II Wagner Ulcer
w/ transcutaneous
oxygen tension of
> 30mmHg,
serum albumin
> 35g/dL

-multiple
medical comorbidity,
steroid
therapy,
neutrophil
count less than
2000/mm3

0

-groups 1&2 ulcers
cleaned with saline and
treated with 1-3 g
PEDYPHAR ointment
-group 3 had limited
excision of gangrenous
tissue and surgical
debridement and then
treated with 1-3 g
PEDYPHAR ointment
changed 2x wkly
-wound was debrided, and
washed with saline, and
honey impregnated gauze
was then applied to the
wound and a fluffy
dressing was applied with
bandage to keep gauze in
place. Dressings were
changed when soaked
-wounds were cleaned
with saline; a thin layer of
honey was poured on
wound and covered with
sterile gauze or for control
the wound was coved
with povidone-soaked
gauze; dressings were
changed on daily basis.

RCT

30

Mean
age=
52.3

Single
blind RCT

30

31-65

OUTCOMES MEASURED
Abdelatif et al. measured the percent of patients to reach full healing and duration for
them to reach that state. Wound healing was assessed by the odor, nature of wound exudates,
erythema, edema, bacterial load and degree of cellulitis or bone infection at 3,9 and 24 weeks.8
Moghazy et al., recorded percent of patients healed and time for healing to occur by assessing
changes ulcer size, inflammation, exudates, grade and stage of wound using the University of
Texas Diabetic Wound Classification which classifies by the stage from A which is no infection
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or ischemia to D where there is infection and ischemia, in addition to a Grade which is from 0
with an epithelized wound to a 3 where the wound penetrates a bone or joint.5 The outcomes
measured in Shukrimi et al. were number of days for the ulcer to reach a proper state for wound
closure assessed by qualitative measurements of granulation, epithelialization, and wound
contracture.9
RESULTS
Shukrimi et al. compared clean, non-sterile pure honey as a wound dressing to Povidone
Iodine (10%) solution as the control, in patients admitted for surgery with Wagner grade-II
diabetic foot ulcers defined as a deep ulcer that penetrates down to the ligament or muscle
without bone involvement or abscess formation8. This study reported continuous data that could
not be converted to dichotomous. Mean days for healing was recorded and compiled from
assessment of wounds by a surgeon blinded to the dressing material. With the use of the honey
dressing mean days for healing was 14.4 days where number of days ranged from 7-26. The
control group resulted in 15.4 days with a range from 9-36 days and the p-value for this data was
less than 0.005 (Table 2). With a difference in mean days of approximately 1, the p-value makes
this data statistically significant and the small difference in days was not due to chance alone but
rather to the use of honey as a dressing which allowed for similar healing time between the
honey group and control group. While the difference in healing time between the two groups is
not drastically different this data is statistically significant and portrays the equality of the two
products in healing diabetic foot ulcers.9
Table 2. Efficacy of Honey vs Povidone Iodine in Wagner grade II diabetic foot ulcers from.9
Treatment Type

Mean number of days
to heal ulcer

Range of days to heal
ulcer

Control (Povidone Iodine)
Honey (Experimental)

15.4 days
14.4 days

9-36 days
7-26 days

Statistical Significance
p<0.005
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Moghazy et al. reported values for the effectiveness of pure, raw untreated honey as a
wound dressing for patients with any staged diabetic foot ulcer reporting to the surgery
department. The control group comparison for this RCT was considered to be all prior treatments
in the same 30 patients that had failed, determined by having no improvement in their ulcers for
a 3 month period. This study had continuous data that was converted to dichotomous. Reported
values included the control event rate (CER), which was 0; because all of the prior treatments
had failed, the study considered all of the controls as a 0% success rate. The value reported for
full success of the honey treatment was 43.3% (0.43) and this was the experimental event rate
(EER). The relative risk reduction (RRR) was calculated as 0. The calculated absolute risk
reduction (ARR) equaled 0.43 and the number needed to treat (NNT) was 3 patients (Table 3).5
The calculation of 0 for a RRR indicates there is a 100% difference in healing of wounds
in comparing the control treatments and experimental honey treatment. In other words, the
control treatments were completely unsuccessful. Therefore, the ARR is equal to the percent of
the subjects that reached wound closure due to honey treatment. Finally, a NNT of 3, means that
3 patients with diabetic foot ulcers need to be treated with honey in order to have 1 additional
patient benefit from the use of honey. This study reported that another 43.3% did have a decrease
in their ulcer size with some healthy granulation tissue, but never reached a full healing by the
completion of the study.5
The mean duration of time for the 43.3% of patients to reach wound closure was
determined to be 2.3± 0.94 weeks (p-value= 0.0089) (Table 4). This value of days to reach
wound closure is again statistically significant due to the low p-value. The days for wound
healing to occur were not just by chance alone but rather due to the experimental honey use.5
Table 3. Efficacy of Honey vs previously failed treatments from Moghazy et al. 2010.5
Study

Control
Event Rate

Experimental
Event Rate

Relative
Risk Ratio

Absolute
Risk Ratio

Number
Needed to

Statistical
Significance
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Moghazy5

(CER)
0

(EER)
0.433

(RRR)
0

(ARR)
0.433

Treat (NNT)
2.3 (3)

(p-value)
p=0.0089

Table 4. Outcome of Honey Dressing on Wound closure patients from Moghazy et al. 20105
1 month
Result of Dressing:
# of Pts
4
Wound closure
Mean Duration of Healing
Standard Deviation

Percent
13.3 %
2.3 weeks
0.94

2 months
# of Pts
4

Percent
13.3%

3 months
# of Pts
5

P-Value

Percent
16.7%

Total
# of Pts
13

Percent
43.3%

0.0089

The final pilot prospective study by Abdelatif et al., reported percent of patients that
improved from their baseline diabetic foot ulcer with the use of PEDYPHAR a new ointment
that combines natural honey and panthenol. Patients were placed into one of 3 groups based on
severity of their foot ulcer. This determination was done using the Wagner classification of
diabetic foot lesions (Group 1= full thickness: Wagner grades 1&2; Group 2= deep tissue
infection or osteomyelitis suspected: Wagner grade 3; Group 3= gangrenous lesions: grade 4 and
5). Clinical responses were recorded at 3, 9, and 24 weeks. Of the 60 patients 50 belonged to
Group 1 (26) or 2 (24) and 10 belonged to group 3. The patients in group 3 underwent surgical
procedures prior to the treatment with PEDYPHAR, but all healed within 2 months of treatment.8
The remaining 50 patients had conservative treatment with only PEDYPHAR ointment.
Of these patients, 96% reached wound closure without complication noted by the 9 week mark.
All patients in group 1 attained full healing. However, 3 patients in group 2 (8%) failed the
conservative PEDYPHAR treatment resorting to amputation, while the remaining 92%
responded to the honey ointment with full healing (Table 5).8
Table 5. Efficacy of PEDYPHAR Honey Ointment on limb threatening Diabetic Foot Ulcers at
weeks 3,9, and 24 in Groups 1 and 2 from Abdelatif et al. 2008.8
Group
Group 1 (n=26)
Group 2 (n=24)

Week 3
Cured= 25 Improved= 1
Cured=10
Improved= 13
Failure= 1

Week 9
Cured=26
Cured= 23
Improved= 1
Failure= 1

Week 24
Cured=26
Cured= 23
Improved= 1
Failure= 1
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In reporting adverse effects of the honey in treatment of diabetic foot ulcers, only the
Pilot prospective study reported such events. The PEDYPHAR ointment used in this study did
contain panthenol rather than plain pure honey so this may have had some responsibility of the
side effect on the patients. Of the 60 patients in this study by Abdelatif, et al. 2008, 4 patients
reported a mild burning sensation with the use of the honey ointment, but this did not cause them
to stop using the product.8 The 2 RCT studies did not mention any adverse effects of the pure
honey treatment.5,9
DISCUSSION
As the resistance of bacteria cultivating wound infections increases there is a greater need
to find antibiotic ointments that are effective in decreasing bacterial load in addition to being cost
efficient. In 2007, the FDA approved a drug called MEDIHONEY manufactured by Derma
Sciences, which is a medical active Manuka honey from New Zealand, that is prepared on
dressing material indicated for mildly exudative wounds including diabetic foot ulcers, leg ulcers
(venous and arterial), pressure ulcers (partial and full thickness), 1st and 2nd degree partial
thickness burns, donor sites and traumatic/surgical wounds.10 This product is not found in most
pharmacies, and can be very expensive as most insurance plans do not cover its use.10
The studies focused on in this review researched the natural commercial honey product
for consumption. This would be a cost effective alternative to other dressing treatments.
Shukrimi et al. found significant data that supports the use of honey in Diabetic Foot Ulcers. This
study only focused on Wagner grade-II lesions though, which leaves one to be unsure of the
deeper lesions as Wagner grading scale goes up to a grade 5. This study fails to report the
number of patients that reached a healing state ready for surgical closure verse failing the
treatment and needing debridement, so although the days for healing in the honey group was
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much less than for the control, more subjects may have completely failed the honey treatment
and that was not reported.9
Moghazy et al. found a statistically significant value for patients fully healed and in a
relatively short duration of time. It also had the low number of 3 for the NNT. This study had the
main limitation of not reporting the previous failed treatments, and they did not provide one
specific control within this study for comparison. Obvious from this study and others honey was
found to be effective in decreasing exudates, bacterial load of skin wounds, and by keeping the
wound moist it caused less pain with removal and allows for a better healing environment for the
new granulation tissue formation for a lesser cost compared to commonly used dressings5,8,9,10,11.
Abdelatif et al. also found data to support that honey is an effective treatment for diabetic
foot ulcers. This study also helped to evaluate those patients with deeper ulcers at Wagner grade
4 and 5. The main limitation to this pilot study is that it is not an RCT so we did not have a
control group for comparison and other treatments were done before using the honey.8
In addition to limitations mentioned above, all of these studies had small subject sizes
and only one was single blinded. Blinding the evaluator of the wound is the most important for
these studies. Patient blinding would not be needed because this is an objective assessment of
their healing process. Limitations in searching for articles in this field were present because
honey is a natural product that is not commonly used or thought of as a type of wound dressing.
In addition, there are many different types of wound dressings manufactured by different
pharmaceutical companies and trials are done commonly to test those products, but there was not
a lot of research to be found for this natural product. There were only 2 RCTs found and those
were the 2 used in this review.
CONCLUSION
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The three studies used in this review all reported supportive data for effectiveness of
honey in the treatment of diabetic foot ulcers. The data from Shukrimi et al, reported a
statistically significant value for days to heal for honey dressing that was comparable to a more
common solution that is used in treatment of foot ulcers. Moghazy et al. reported that with honey
use, majority of the subjects reached improvements with their ulcers, and finally in the pilot
prospective study subjects data that was reported portrayed high percentages of healing in a
relatively short duration of time.
Future studies need to be done in this field of diabetic foot ulcers to determine at what
level of a diabetic foot ulcer honey would be most efficient. In the studies included in this review
this was not explicitly discovered. The Shukrimi et al. found significant data for Wagner grade-II
lesions, but did not investigate ulcers worse than that grade. Moghazy et al used a different
classification system making it hard to compare the work by Shukrimi et al. A study should be
done with a certain number of subjects to fulfill both classification system requirements and
compared. Also honey should be compared to other different types of dressings, because this
review only contained an RCT comparing honey to Povidone Iodine.
In addition, honey needs to be standardized. Shukrimi et al. did not state if the honey they
used was raw which would be non- heat treated. This could have some affect on results and
wound healing if certain properties are changed by the heat, so a standard honey product also
needs to be used. A study could be done to compare wound healing with raw honey vs. heat
treated honey packaged for human consumption to see if there is any difference in its
effectiveness.
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